These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17549245)

  • 1. The Canadian Natural Health Products (NHP) regulations: industry compliance motivations.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    Evid Based Complement Alternat Med; 2007 Jun; 4(2):257-62. PubMed ID: 17549245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    BMC Health Serv Res; 2006 May; 6():63. PubMed ID: 16734916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The professionalization of Western herbalists: response to new product regulations in Canada.
    Moss K; Boon H; Ballantyne P; Kachan N
    Complement Ther Med; 2007 Dec; 15(4):264-70. PubMed ID: 18054728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues of environmental compliance in developing countries.
    Singh S; Rajamani S
    Water Sci Technol; 2003; 47(12):301-4. PubMed ID: 12926702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal and financial constraints and firm growth: small and medium enterprises (SMEs) versus large enterprises.
    Bui AT; Pham TP; Pham LC; Ta TKV
    Heliyon; 2021 Dec; 7(12):e08576. PubMed ID: 34977406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with ivory trade regulations in the United Kingdom among traders.
    Harris L; Gore M; Mills M
    Conserv Biol; 2019 Aug; 33(4):906-916. PubMed ID: 30623981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An innovative model for regulating supplement products: natural health products in Canada.
    Nestmann ER; Harwood M; Martyres S
    Toxicology; 2006 Apr; 221(1):50-8. PubMed ID: 16472903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational Health Problems and Safety Conditions among Small and Medium-Sized Enterprises: A Cross-sectional Study in Shiraz, Iran.
    Jahangiri M; Azmon H; Daneshvar A; Keshmiri F; Khaleghi H; Besharati A; Daneshvar S; Hassanipour S; Malakoutikhah M
    Ann Glob Health; 2019 Apr; 85(1):. PubMed ID: 30951272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency.
    Carr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):20-3. PubMed ID: 20101799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory qualitative study to understand the underlying motivations and strategies of the private for-profit healthcare sector in urban Bangladesh.
    Adams AM; Ahmed R; Shuvo TA; Yusuf SS; Akhter S; Anwar I
    BMJ Open; 2019 Jul; 9(7):e026586. PubMed ID: 31272974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivation for compliance with environmental regulations related to forest health.
    Peterson K; Diss-Torrance A
    J Environ Manage; 2012 Dec; 112():104-19. PubMed ID: 22890000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA.
    Kondo H; Shibatsuji M; Yasuda N
    Ther Innov Regul Sci; 2019 Mar; 53(2):193-198. PubMed ID: 29719977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental strategy and performance in small firms: a resource-based perspective.
    Aragón-Correa JA; Hurtado-Torres N; Sharma S; García-Morales VJ
    J Environ Manage; 2008 Jan; 86(1):88-103. PubMed ID: 17239519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Cluster Randomized Controlled Trial to Promote the Use of Respiratory Protective Equipment among Migrant Workers Exposed to Organic Solvents in Small and Medium-Sized Enterprises.
    Chen W; Li T; Zou G; Renzaho AMN; Li X; Shi L; Ling L
    Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31480482
    [No Abstract]   [Full Text] [Related]  

  • 15. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health and well-being in small and medium-sized enterprises (SMEs). What public health support do SMEs really need?
    Holt M; Powell S
    Perspect Public Health; 2015 Jan; 135(1):49-55. PubMed ID: 24535003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Company integration management in small and medium-sized companies. Legal requirements and prerequisites for successful implementation].
    Ramm D; Mahnke C; Tauscher A; Welti F; Seider H; Shafaei R
    Rehabilitation (Stuttg); 2012 Jan; 51(1):10-7. PubMed ID: 22311393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge Management in Health Technology SMEs.
    Huusko J; Kuusisto-Niemi S; Saranto K
    Stud Health Technol Inform; 2017; 245():878-881. PubMed ID: 29295225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDPRValidator: a tool to enable companies using cloud services to be GDPR compliant.
    Cambronero ME; Martínez MA; de la Vara JL; Cebrián D; Valero V
    PeerJ Comput Sci; 2022; 8():e1171. PubMed ID: 36532816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of three chiral flavonoids with reported bioactivity in selected licensed Canadian natural health products and US marketed dietary supplements.
    Sayre CL; Davies NM
    J Pharm Pharm Sci; 2013; 16(2):272-8. PubMed ID: 23958196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.